Presence of memory T cells and naturally acquired antibodies in plasmodium vivax malaria-exposed individuals against a group of tryptophan-rich antigens with conserved sequences

Journal of Infectious Diseases

Volumn 207, Issue 1, 2013, Pages 175-185

  Zeeshan, Mohammad ^a   Bora, Hema ^a   Sharma, Yagya Dutta ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

CD4+ T cells; Cytokines; Humoral and cellular immune responses; Tryptophan rich antigens; Vivax malaria

Indexed keywords

CD69 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 2; INTERLEUKIN 4; PARASITE ANTIGEN; TRYPTOPHAN;

AMINO ACID SUBSTITUTION; ANTIGEN EXPRESSION; ANTIGEN PURIFICATION; ARTICLE; BLOOD SAMPLING; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; GENE SEQUENCE; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; MALARIA; MEMORY T LYMPHOCYTE; NUCLEOTIDE SEQUENCE; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PRIORITY JOURNAL; SEQUENCE ALIGNMENT; TH1 CELL; TH2 CELL; UNINDEXED SEQUENCE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; BASE SEQUENCE; CONSERVED SEQUENCE; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; INDIA; INTERFERON-GAMMA; INTERLEUKIN-2; INTERLEUKIN-4; MALARIA, VIVAX; MOLECULAR SEQUENCE DATA; PLASMODIUM VIVAX; POLYMORPHISM, GENETIC; RECOMBINANT PROTEINS; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; T-LYMPHOCYTES; TH1 CELLS; TH2 CELLS; TRYPTOPHAN;

EID: 84872897265     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis650     Document Type: Article

References (41)

1. Malaguarnera L, Musumeci S. The immune response to Plasmodium falciparum malaria. Lancet Infect Dis 2002; 2:472-8.
2. Schuerwegh AJ, De Clerck LS, Bridts CH, Stevens WJ. Comparison of intracellular cytokine production with extracellular cytokine levels using two flow cytometric techniques. Cytometry B Clin Cytom 2003; 55:52-8.
3. Butcher GA, Garland T, Ajdukiewicz AB, Clark IA. Serum tumor necrosis factor associated with malaria in patients in the Solomon Islands. Trans R Soc Trop Med Hyg 1990; 84:658-61.
4. Karunaweera ND, Grau GE, Gamage P, Carter R, Mendis KN. Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria. Proc Natl Acad Sci U S A 1992; 89:3200-3.
5. Seoh JY, Khan M, Park SH, et al. Serum cytokine profiles in patients with Plasmodium vivax malaria: a comparison between those who presented with and without hyperpyrexia. Am J Trop Med Hyg 2003; 68:102-6.
6. Kim TS, Chung YB, Choi HJ, Yang HJ. Changes of serum cytokine profiles in Korean vivax malarial patients after chemotherapy. Parasitol Res 2006; 100:183-5.
7. Mitchell GH. An update on candidate malaria vaccines. Parasitology 1989; 98 (Suppl):S29-47.
8. Arnot DE, Cavanagh DR, Remarque EJ, et al. Comparative testing of six antigen-based malaria vaccine candidates directed toward merozoite- stage Plasmodium falciparum. Clin Vaccine Immunol 2008; 15:1345-55.
9. Burns JM Jr., Adeeku EK, Dunn PD. Protective immunization with a novel membrane protein of Plasmodium yoelii-infected erythrocytes. Infect Immun 1999; 67:675-80.
10. Burns JM Jr., Dunn PD, Russo DM. Protective immunity against Plasmodium yoelii malaria induced by immunization with particulate blood-stage antigens. Infect Immun 1997; 65:3138-45.
11. Garraud O, Diouf A, Holm I, Perraut R, Longacre S. Immune responses to Plasmodium falciparum-merozoite surface protein 1 (MSP1) antigen, II. Induction of parasite-specific immunoglobulin G in unsensitized human B cells after in vitro T-cell priming with MSP119. Immunology 1999; 97:497-505.
12. Hoffman SL, Oster CN, Mason C, et al. Human lymphocyte proliferative response to a sporozoite T cell epitope correlates with resistance to falciparum malaria. J Immunol 1989; 142:1299-303.
13. John CC, Ouma JH, Sumba PO, Hollingdale MR, Kazura JW, King CL. Lymphocyte proliferation and antibody responses to Plasmodium falciparum liver-stage antigen-1 in a highland area of Kenya with seasonal variation in malaria transmission. Am J Trop Med Hyg 2002; 66:372-8.
14. Kumar S, Miller LH, Quakyi IA, et al. Cytotoxic T cells specific for the circumsporozoite protein of Plasmodium falciparum. Nature 1988; 334:258-60.
15. Malik A, Egan JE, Houghten RA, Sadoff JC, Hoffman SL. Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein. Proc Natl Acad Sci U S A 1991; 88:3300-4.
16. Sachdeva S, Ahmad G, Malhotra P, Mukherjee P, Chauhan VS. Comparison of immunogenicities of recombinant Plasmodium vivax merozoite surface protein 1 19- and 42-kiloDalton fragments expressed in Escherichia coli. Infect Immun 2004; 72:5775-82.
17. Suphavilai C, Looareesuwan S, Good MF. Analysis of circumsporozoite protein-specific immune responses following recent infection with Plasmodium vivax. Am J Trop Med Hyg 2004; 71:29-39.
18. Thomas BE, Sridevi K, Chopra N, Haq W, Rao DN. Inducing a cellmediated immune response against peptides of the Plasmodium vivax circumsporozoite protein. Ann Trop Med Parasitol 2001; 95:573-86.
19. Ntumngia FB, Bouyou-Akotet MK, Uhlemann AC, Mordmuller B, Kremsner PG, Kun JF. Characterization of a tryptophan-rich Plasmodium falciparum antigen associated with merozoites. Mol Biochem Parasitol 2004; 137:349-53.
20. Uhlemann AC, Oguariri RM, McColl DJ, et al. Properties of the Plasmodium falciparum homologue of a protective vaccine candidate of Plasmodium yoelii. Mol Biochem Parasitol 2001; 118:41-8.
21. Mittra P, Singh N, Sharma YD. Plasmodium vivax: immunological properties of tryptophan-rich antigens PvTRAg 35.2 and PvTRAg 80.6. Microbes Infect 2010; 12:1019-26.
22. Garg S, Chauhan SS, Singh N, Sharma YD. Immunological responses to a 39.8kDa Plasmodium vivax tryptophan-rich antigen (PvTRAg39.8) among humans. Microbes Infect 2008; 10:1097-105.
23. Alam MT, Bora H, Singh N, Sharma YD. High immunogenecity and erythrocyte-binding activity in the tryptophan-rich domain (TRD) of the 74-kDa Plasmodium vivax alanine-tryptophan-rich antigen (PvATRAg74). Vaccine 2008; 26:3787-94.
24. Jalah R, Sarin R, Sud N, et al. Identification, expression, localization and serological characterization of a tryptophan-rich antigen from the human malaria parasite Plasmodium vivax. Mol Biochem Parasitol 2005; 142:158-69.
25. Siddiqui AA, Bora H, Singh N, Dash AP, Sharma YD. Expression, purification, and characterization of the immunological response to a 40- kilodalton Plasmodium vivax tryptophan-rich antigen. Infect Immun 2008; 76:2576-86.
26. Siddiqui AA, Singh N, Sharma YD. Expression and purification of a Plasmodium vivax antigen - PvTARAg55 tryptophan- and alaninerich antigen and its immunological responses in human subjects. Vaccine 2007; 26:96-107.
27. Alam MT, Bora H, Mittra P, Singh N, Sharma YD. Cellular immune responses to recombinant Plasmodium vivax tryptophan-rich antigen (PvTRAg) among individuals exposed to vivax malaria. Parasite Immunol 2008; 30:379-83.
28. Vinayak S, Mittra P, Sharma YD. Wide variation in microsatellite sequences within each Pfcrt mutant haplotype. Mol Biochem Parasitol 2006; 147:101-8.
29. Lanzavecchia A, Sallusto F. Antigen decoding by T lymphocytes: from synapses to fate determination. Nat Immunol 2001; 2:487-92.
30. Ziegler SF, Ramsdell F, Alderson MR. The activation antigen CD69. Stem Cells 1994; 12:456-65.
31. Rocken M, Saurat JH, Hauser C. A common precursor for CD4+ T cells producing IL-2 or IL-4. J Immunol 1992; 148:1031-6.
32. Openshaw P, Murphy EE, Hosken NA, et al. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J Exp Med 1995; 182:1357-67.
33. Zhang X, Giangreco L, Broome HE, Dargan CM, Swain SL. Control of CD4 effector fate: transforming growth factor beta 1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion. J Exp Med 1995; 182:699-709.
34. Telander DG, Mueller DL. Impaired lymphokine secretion in anergic CD4+ T cells leads to defective help for B cell growth and differentiation. J Immunol 1997; 158:4704-13.
35. Newton CR, Krishna S. Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment. Pharmacol Ther 1998; 79:1-53.
36. Acacia de Sa Pinheiro A, Morrot A, Chakravarty S, et al. IL-4 induces a wide-spectrum intracellular signaling cascade in CD8+ T cells. J Leukoc Biol 2007; 81:1102-10.
37. Scholzen A, Mittag D, Rogerson SJ, Cooke BM, Plebanski M. Plasmodium falciparum-mediated induction of human CD25Foxp3 CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFbeta. PLoS Pathog 2009; 5:e1000543.
38. Sun P, Schwenk R, White K, et al. Protective immunity induced with malaria vaccine, RTS,S, is linked to Plasmodium falciparum circumsporozoite protein-specific CD4+ and CD8+ T cells producing IFNgamma. J Immunol 2003; 171:6961-7.
39. Leoratti FM, Durlacher RR, Lacerda MV, et al. Pattern of humoral immune response to Plasmodium falciparum blood stages in individuals presenting different clinical expressions of malaria. Malar J 2008; 7:186.
40. Mackintosh CL, Christodoulou Z, Mwangi TW, et al. Acquisition of naturally occurring antibody responses to recombinant protein domains of Plasmodium falciparum erythrocyte membrane protein 1. Malar J 2008; 7:155.
41. Gascan H, Gauchat JF, Roncarolo MG, Yssel H, Spits H, de Vries JE. Human B cell clones can be induced to proliferate and to switch to IgE and IgG4 synthesis by interleukin 4 and a signal provided by activated CD4+ T cell clones. J Exp Med 1991; 173:747-50.